http://www.lovecleanstreets.org/Reports/Home
- http://www.bbits.co.uk/ - Love Clean Streets™ is our award winning
mobile and cloud based service. Citizens can report environmental crime
such as graffiti, fly-tipping or potholes though their mobile phones;
authorities can manage and respond through our integrated services.Good
apps for iPad touch, good apps, good apps for iPhone 4, good apps for
android, good apps for iPhone, good apps for iPod, great apps for iPod
touch, great apps, great apps for android, boris Johnson tackle, boris
Johnson, boris Johnson letterman, steve ballmer going crazy, steve
ballmer, steve ballmer developers, steve ballmer iPhone, steve ballmer
funny, x factor app, windows azure, windows 8, windows phone 8, windows
8 preview, cloud based applications, cloud based services, cloud based
computing, cloud based gaming
Luzaida Cuevas was told that her infant daughter Delimar had died in a fire in their Philadelphia apartment. But she always believed that her daughter was still alive, and six years later she saw a little girl at a birthday party that she knew in her heart was Delimar. Despite the skepticism of everyone around her, she set out to prove that the little girl was her missing daughter. Premieres Sunday 8/17 at 8pm ET on Lifetime Movie Network.
Luzaida Cuevas was told that her infant daughter Delimar had died in a fire in their Philadelphia apartment. But she always believed that her daughter was still alive, and six years later she saw a little girl at a birthday party that she knew in her heart was Delimar. Despite the skepticism of everyone around her, she set out to prove that the little girl was her missing daughter. Premieres Sunday 8/17 at 8pm ET on Lifetime Movie Network.
Luzaida Cuevas was told that her infant daughter Delimar had died in a fire in their Philadelphia apartment. But she always believed that her daughter was still alive, and six years later she saw a little girl at a birthday party that she knew in her heart was Delimar. Despite the skepticism of everyone around her, she set out to prove that the little girl was her missing daughter. Premieres Sunday 8/17 at 8pm ET on Lifetime Movie Network.
Visionworks and Davis Vision kicked off 2017 continuing their work to raise awareness about the importance of annual eye exams for school-aged children by increasing the number of vouchers and glasses they will donate this school year from 10,000 to 15,000. Through their joint initiative, Let’s Go See has already donated more than 8,300 vouchers since the 2016-17 school year started.
“The Let's Go See program has been instrumental in our efforts to spread awareness of the need for annual eye exams for school-aged children. We feel honored to help families provide eye exams and glasses to their kids, and look forward to continuing our mission,” said Jim Eisen, president and CEO of HVHC Inc., and president of Visionworks.
Between dental checkups, doctor's exams, and everything else parents do to keep kids healthy, children’s vision often gets overlooked. Many parents wait until their child has expressed an issue with their vision before taking them for an eye exam, but according to Prevent Blindness America, 1 in 4 school-aged children in the United States has a vision problem, which if left untreated can affect learning ability, personality, and adjustments in school.
To view the multimedia release go to:
http://www.multivu.com/players/English/7938651-visionworks-lets-go-see-childrens-eye-health-awareness/
For the third consecutive year, Legrand, as a global specialist in electrical and digital building infrastructures, is participating in the Consumer Electronics Show (CES) at Las Vegas from January 5 to 8, 2017. To illustrate the accelerated deployment of its Eliot program, Legrand is introducing a new connected home control solution, Céliane with Netatmo, a new connected door entry system, Classe 300, and the Digital Lighting Management system, a connected professional lighting management solution. This focus on the Eliot program is further accentuated by putting the spotlight on Legrand’s partnerships. Coming in the wake of the recent launch of Eliot in the US, this participation at CES 2017 evidences the innovation dynamic nurtured by Legrand around the Internet of Things and the notion of interoperability.
To view the multimedia release go to:
http://www.multivu.com/players/uk/8011051-legrand-ces-2017-eliot-program-dynamic/
Registration for CyberPatriot III is open until October 8, so hurry to enroll your team!
CyberPatriot, established by the Air Force Association, is the nation’s largest and fastest-growing high school cyber defense competition. It was created to inspire high school students to consider careers in cybersecurity or other technology and mathematic disciplines critical to our nation’s future. The deadline to participate in this premier competition is now less than 30 days away.
To view Multimedia News Release, go to http://multivu.prnewswire.com/mnr/airforceassociation/46017/
LeapFrog Enterprises, Inc. (NYSE:LF), the leader in children’s learning tablets, today announced the launch of the ultimate kids’ learning tablet, LeapPad Ultra. The new LeapPad Ultra is kid-tough and works with LeapFrog’s unique library of more than 800 life-changing content experiences designed or approved by LeapFrog’s learning experts. LeapPad Ultra is kid-ready right out of the box with LeapSearch™ by Zui™, a proprietary kid-safe web browser that parents can trust. Unique to LeapPad Ultra, the seven-inch DUO TECH™ high-resolution screen is designed to help children learn to write using a stylus while supporting interactive touch experiences. Additionally, LeapPad Ultra features a sleek new look, a long-lasting rechargeable battery, and front and back cameras and video recorders plus 8 GB of storage for photos, apps, videos and more.
To view Multimedia News Release, go to http://www.multivu.com/mnr/59385-leapfrog-announces-ultimate-learning-tablet-for-kids-leappad-ultra
Sanofi (EURONEXT: SAN and NYSE: SNY) and Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN) today announced that data from two Phase 2 trials with SAR236553/REGN727, an investigational, high-affinity, subcutaneously administered, fully-human antibody targeting PCSK9 (proprotein convertase subtilisin/kexin type 9), were presented at the American College of Cardiology’s (ACC) 61st Annual Scientific Meeting in Chicago.
The data showed that treatment with SAR236553/REGN727 over 8 to 12 weeks significantly reduced mean low-density lipoprotein-cholesterol (LDL-C, or “bad” cholesterol) by 40% to 72% in patients with elevated LDL-C on stable dose of statins.
To view Multimedia News Release, go to http://www.multivu.com/mnr/55299-sanofi-regeneron-pharmaceuticals-lipid-lowering-medications-pcsk9-antibody
